The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: The Ausimmune study
- 13 May 2013
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 19 (13), 1717-1725
- https://doi.org/10.1177/1352458513483887
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.This publication has 30 references indexed in Scilit:
- Smoking and Multiple Sclerosis: A Matter of Global ImportanceNeuroepidemiology, 2011
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis‐like disease in C57BL/6 miceBritish Journal of Pharmacology, 2011
- Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosisMultiple Sclerosis Journal, 2011
- Smoking and Multiple Sclerosis: An Updated Meta-AnalysisPLOS ONE, 2011
- Smoking is a risk factor for early conversion to clinically definite multiple sclerosisMultiple Sclerosis Journal, 2008
- Multiple sclerosis and lifestyle factors: the Hordaland Health StudyNeurological Sciences, 2005
- Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow upJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Caffeine suppresses TNF-α production via activation of the cyclic AMP/protein kinase A pathwayInternational Immunopharmacology, 2004
- Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trialThe Lancet, 2003
- Effects of Cannabinoids on the Immune System and Central Nervous SystemBioDrugs, 1999